PPCB (Propanc Biopharma) Koefisien nilai perusahaan marang pendapatan

Simbol resmi perusahaan Propanc Biopharma Inc (PPCB)

Propanc Biopharma Inc (PPCB) utilizes a fabless model, outsourcing molecule synthesis to third-party contractors. The time trajectory on the GURU.Markets chart, based on the firm's EV/Sales multiple valuation, shows that the indicator reaches 0.00. Demand for targeted therapy is rising across medical centers, while environmental safety is ensured by closed-loop water purification at the company's pilot facilities.

Propanc Biopharma Inc. (PPCB): Multiplikator EV/Sales saka 23.11.2025 nganti 20.11.2026

Rincian metrik keuangan lan pasar Propanc Biopharma, Inc. (PPCB)

Pambiji fundamental perusahaan:Propanc Biopharma Inc. PPCB
Sampel barang Propanc Biopharma Inc.

For Propanc Biopharma Inc (PPCB), the efficiency of managing complex cold chain logistics for oncology drugs directly impacts capitalization, making the EV/Sales metric critical for valuing the business regardless of debt load. By analyzing the company's current enterprise value to revenue, an investor determines the fair multiplier paid per unit of income, identifying whether the asset is overbought or possesses growth potential relative to historical values.